Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006;14(5):567-86.
doi: 10.1007/s10577-006-1055-4. Epub 2006 Jul 12.

The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study

Affiliations

The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study

J Chaudhary et al. Chromosome Res. 2006.

Abstract

Genetic instability may lead to the loss/gain of transcriptional control. Here we investigated the effect of genomic instability, that is loss/gain of chromosomal regions on the global transcriptome of prostate cancer cell line DU145. The genomic loss/gain map obtained through BAC array-based CGH was superimposed on the dynamic transcriptome of DU145 cells treated with serum for 0 h (serum starved), 2 h and 12 h. The genomic analysis suggested that in DU145 cells: (1) chromosomal gains are prominent than losses and (2) copy number changes are associated with chromosome-specific and dynamic gene expression regulatory mechanisms. A significant proportion of the genes in the stable regions of the chromosome were up-regulated whereas a higher proportion of genes were down-regulated at 2 and 12 h in the deleted regions of the chromosomes following serum treatment. No change in expression was observed for the genes in the gained regions over a period of time. This analysis led us to propose that loss of heterozygosity leads to an overall transcriptional down-regulation that may further lead to a decrease in the expression of putative tumor suppressors. The genomic profile of DU145 is similar to pathological specimens of prostate cancer, hence the genomic/transcriptomic signature of DU145 can be used to understand the pathology of prostate cancer. It is expected that this analysis will allow a better understanding of transcriptional regulatory mechanisms in the context of genomic loss and gain and may lead to the discovery of novel oncogenes and tumor suppressors and the underlying regulatory pathways.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nat Genet. 1998 Oct;20(2):207-11 - PubMed
    1. Physiol Genomics. 2003 Mar 18;13(1):31-46 - PubMed
    1. Cancer Metastasis Rev. 2001;20(3-4):173-93 - PubMed
    1. Carcinogenesis. 2004 Aug;25(8):1345-57 - PubMed
    1. Cancer Res. 2002 Jun 15;62(12):3466-76 - PubMed

Publication types

LinkOut - more resources